Literature DB >> 23387894

Spontaneous remission of chemo-immunotherapy related, non-transplant Epstein-Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia.

Preetesh Jain1, Ohad Benjamini, Sergej Konoplev, Mohamed Shamel Mohamed, Carlos Guillermo Romo, Zeev Estrov.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23387894      PMCID: PMC4103649          DOI: 10.3109/10428194.2013.773995

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  11 in total

1.  Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis.

Authors:  Michihide Tokuhira; Reiko Watanabe; Tomoe Nemoto; Morihiko Sagawa; Tatsuki Tomikawa; Jun-ichi Tamaru; Shinji Itoyama; Hayato Nagasawa; Koichi Amano; Hideto Kameda; Tsutomu Takeuchi; Shigehisa Mori; Masahiro Kizaki
Journal:  Leuk Lymphoma       Date:  2011-11-25

Review 2.  EBV-associated lymphomas in adults.

Authors:  Mark Roschewski; Wyndham H Wilson
Journal:  Best Pract Res Clin Haematol       Date:  2012-02-05       Impact factor: 3.020

Review 3.  Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly.

Authors:  Patrick Adam; Irina Bonzheim; Falko Fend; Leticia Quintanilla-Martínez
Journal:  Adv Anat Pathol       Date:  2011-09       Impact factor: 3.875

4.  Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features.

Authors:  Abner Louissaint; Judith A Ferry; Chad P Soupir; Robert P Hasserjian; Nancy L Harris; Lawrence R Zukerberg
Journal:  Mod Pathol       Date:  2012-05-25       Impact factor: 7.842

5.  Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.

Authors:  O W Kamel; M van de Rijn; L M Weiss; G J Del Zoppo; P K Hench; B A Robbins; P G Montgomery; R A Warnke; R F Dorfman
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

6.  Immunomodulator agent-related lymphoproliferative disorders.

Authors:  Robert P Hasserjian; Steve Chen; Sherrie L Perkins; Laurence de Leval; Marsha C Kinney; Todd S Barry; Jonathan Said; Megan S Lim; William G Finn; L Jeffrey Medeiros; Nancy L Harris; Dennis P O'Malley
Journal:  Mod Pathol       Date:  2009-09-18       Impact factor: 7.842

7.  Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2007-09

8.  Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks.

Authors:  Jennifer H Anolik; Rajan Ravikumar; Jennifer Barnard; Teresa Owen; Anthony Almudevar; Eric C B Milner; Chase H Miller; Paul O Dutcher; James A Hadley; Iñaki Sanz
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 9.  The immunodeficiency of chronic lymphocytic leukaemia.

Authors:  A D Hamblin; T J Hamblin
Journal:  Br Med Bull       Date:  2008-08-27       Impact factor: 4.291

10.  Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.

Authors:  Eva Baecklund; Christer Sundström; Anders Ekbom; Anca I Catrina; Peter Biberfeld; Nils Feltelius; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2003-06
View more
  1 in total

1.  CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation.

Authors:  Preetesh Jain; Jan A Burger; Joseph D Khoury
Journal:  Am J Hematol       Date:  2017-08-10       Impact factor: 10.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.